Patent details

EP3297631 Title: NK-1/NK-3 RECEPTOR ANTAGONIST FOR THE TREATMENT OF HOT FLUSHES

Basic Information

Publication number:
EP3297631
PCT Application Number:
EP2016060945
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP167231075
PCT Publication Number:
WO2016184829
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NK-1/NK-3 RECEPTOR ANTAGONIST FOR THE TREATMENT OF HOT FLUSHES
French Title of Invention:
ANTAGONISTE DES RÉCEPTEURS NK-1/NK-3 DESTINÉ AU TRAITEMENT DES BOUFFÉES DE CHALEUR
German Title of Invention:
NK-1/NK-3-REZEPTOR-ANTAGONIST ZUR BEHANDLUNG DER HITZEWALLUNG
SPC Number:

Dates

Filing date:
16/05/2016
Grant date:
04/09/2019
EP Publication Date:
28/03/2018
PCT Publication Date:
24/11/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/09/2019
EP B1 Publication Date:
04/09/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
16/05/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/02/2021
 
 

Name:
KANDY THERAPEUTICS LIMITED
Address:
400 South Oak Way, Reading, RG2 6AD, Berkshire, United Kingdom (GB)

History of Owners

From:
28/08/2019
To:
05/02/2021

Name:
NeRRe Therapeutics Limited
Address:
Stevenage Bioscience Catalyst Office F25 Incubator Building Gunnels Wood Road, Stevenage, Hertfordshire SG1 2FX, United Kingdom (GB)

Agent

Name:
MURGITROYD & COMPANY
From:
10/09/2019
Address:
SCOTLAND HOUSE, SCOTLAND STREET 165-169, G5 8PL, GLASGOW / SCOTLAND, United Kingdom (GB)
To:

Inventor

Name:
TROWER, Mike
Address:
United Kingdom (GB)

Priority

Priority Number:
201562162870 P
Priority Date:
18/05/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/5383; A61P 5/24; A61P 43/00;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2021/04
Publication date:
08/03/2021
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:
201936
Publication date:
04/09/2019
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20210000055A
Date Registered:
05/02/2021
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
MURGITROYD & COMPANY
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
KANDY THERAPEUTICS LIMITED
Address:
400 South Oak Way, Reading, RG2 6AD, Berkshire, United Kingdom (GB)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
02/06/2025
Annual Fee Number:
10
Annual Fee Amount:
131 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/05/2024
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
19/09/2019 Outgoing Correspondence 1
10/09/2019 Power Of Attorney 1
05/02/2021 Request For Change 4